-
Recent Posts
- Galcanezumab in Chronic Migraine
- Disease Modifying Therapies in Multiple Sclerosis: Background for General Readers
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- Detection of Brain Activation in Vegetative State by Standard Electroencephalography
- Double-Blind Double-Dummy Randomised Study of Continuous Intrajejunal infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease
Archives
Categories
Meta
Tag Archives: Primary Progressive
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Recent studies indicate that higher strength disease modifying therapies (DMTs) may slow disability progression in secondary progressive multiple sclerosis (MS), as well as reduce the number of relapses. There have also been trials in primary progressive MS but these, most … Continue reading →
